Economic Burden Can Be the Major Determining Factor Resulting in Short-Term Intermittent and Repetitive Ustekinumab Treatment for Moderate-to-Severe Psoriasis

BACKGROUND: The continuous use of biologic agents in the treatment of psoriasis has been reported to result in successful and sustained therapeutic effects and safety. However, some patients choose intermittent and repetitive treatment. OBJECTIVE: To determine the factors for selecting intermittent...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Chong Won, Choi, Ji Young, Kim, Bo Ri, Youn, Sang Woong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Dermatological Association; The Korean Society for Investigative Dermatology 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5839889/
https://www.ncbi.nlm.nih.gov/pubmed/29606815
http://dx.doi.org/10.5021/ad.2018.30.2.179

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5839889/
https://www.ncbi.nlm.nih.gov/pubmed/29606815
http://dx.doi.org/10.5021/ad.2018.30.2.179

Ejemplares similares